What does NeoMed-Jersey invest in?
NeoMed-Jersey invests most often at Series A and Series B (50% of the rounds on record).
NeoMed-Jersey highlights
- 01
4 rounds on record
- 02
Mostly Series A and Series B: 50% of its rounds
- 03
2 exits from the portfolio
What they do
- Type
- Investment firm (from a list, unverified)
- Cheque size
- Not stated
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first4 appearances
- 2014
2 rounds
- Apr
- Mar
- 2006
1 round
- Dec
- 2003
1 round
- Apr
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
Exits from the portfolio
Companies it backed that were later bought or listed2 in all
Xanthus PharmaceuticalsBought by AntisomaUndisclosedMay 2008
Oxxon TherapeuticsBought by Oxford BioMedicaUndisclosedMar 2007
An exit counts when it came after the firm's first round in the company. From historical deal records.